Stem Cell Treatment in Diabetes

It is possible to treat Type 1 diabetes by transplanting confined islet cells, containing beta cells or even an entire pancreas into the patient from a contributor. Transplants will empower the body to take back management of aldohexose levels therefore administrating hypoglycaemic agent is rarely once more needed. The global stem cell market is look to reach USD 15.63billion by 2025, growing at a CAGR of 9.2%, Inc. Augmentation in analysis studies that point at broadening the utility scope of associated merchandise is anticipated to drive the market growth. These analysis comes have opened the chance of execution of many clinical applications of those cells, thereby impacting disease-modifying treatments.

  • Kidney damage (nephropathy)
  • Unexplained weight loss
  • Alzheimer’s disease
  • Glucose tolerance test

Related Conference of Stem Cell Treatment in Diabetes

July 27-28, 2026

3rd World Pediatric Conference

London, UK
August 18-19, 2026

8th World Pediatric Infectious Disease Congress

Paris, France
September 07-08, 2026

24rd World Congress on Clinical Pediatrics

Toronto, Canada
September 14-15, 2026

26th Annual Congress on Pediatrics & Neonatology

Rome, Italy
October 05-06, 2026

39th World Pediatrics Conference

Madrid, Spain
November 19-20, 2026

37th European Pediatrics Conference

Dubai, UAE
December 03-04, 2026

11th Annual Pediatric Congress

Madrid, Spain
December 29-30, 2026

35th World Congress on Clinical Pediatrics

Edinburgh, Scotland
March 25-26, 2027

6th World Congress on Pediatric Cardiology

Amsterdam, Netherlands

Stem Cell Treatment in Diabetes Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in